Author

A. Urbanucci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Research Focus:gene regulatory network inference· 3 Approach:statistical model· 3 Approach:experimental assay· 2 Assay:scRNA-seq· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

M. Nykter· 4 shared T. Visakorpi· 3 shared A. Erickson· 2 shared A. Kiviaho· 2 shared E. Afyounian· 2 shared F. Claessens· 2 shared G. Attard· 2 shared I. G. Mills· 2 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

M. Nykter

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Immunosuppression in the prostate tumor microenvironment is tied to androgen deprivation therapy-resistant club-like cells

A. Kiviaho, S. K. Eerola, H. M. L. Kallio, M. K. Andersen, X. Spotbeen, A. Giesen, C. T. A. Parker, S. Taavitsainen, O. Hantula, M. Marttinen, I. Hermelo, M. Ismail, E. Midtbust, M. Wess, W. Devlies, , M. Nykter

The paper identifies club-like cells in the prostate tumor microenvironment that contribute to androgen deprivation therapy resistance through immune suppression.

bioRxiv · Mar 25, 2024 · PreprintCancer Biology

ABI1 regulates transcriptional activity of Androgen Receptor by novel DNA and AR binding mechanism

B. A. Porter, X. Li, N. Arya, F. Zhang, S. H. Y. Kung, L. Fazli, H. Zarni Oo, Y. Li, K. Marincin, K. Kukkonen, H. Urhonen, M. A. Ortiz, A. P. Kemraj, E. Corey, X. Dong, , L. Kotula

This paper identifies ABI1 as an epigenetic regulator of transcriptional homeostasis in AR-driven cancers through novel DNA and AR binding mechanisms.

bioRxiv · May 26, 2023 · PreprintCancer Biology

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer

S. Taavitsainen, N. Engedal, S. Cao, F. Handle, A. Erickson, S. Prekovic, D. Wetterskog, T. Tolonen, E. M. Vuorinen, A. Kiviaho, R. Nätkin, T. Häkkinen, W. Devlies, S. Henttinen, R. Kaarijärvi, , A. Urbanucci

The paper uses single-cell ATAC and RNA sequencing to identify pre-existing and treatment-persistent stem-like cell subpopulations in prostate cancer models that predict treatment response.

bioRxiv · Feb 9, 2021Cancer Biology

Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression

J. Uusi-Mäkelä, E. Afyounian, F. Tabaro, T. Häkkinen, A. Lussana, A. Shcherban, M. Annala, R. Nurminen, K. Kivinummi, T. L. J. Tammela, A. Urbanucci, L. Latonen, J. Kesseli, K. J. Granberg, T. Visakorpi, M. Nykter

The paper analyzes chromatin accessibility in prostate cancer stages to identify regulatory elements and their role in gene expression changes during disease progression.

bioRxiv · Sep 8, 2020 · PreprintCancer Biology